The EVERY Company (ex. Clara Foods) investment overview

EVERY is the market leader in engineering, manufacturing and formulating animal-free, animal proteins as ingredients for the global food and beverage industry, starting with the world’s first chickenless egg proteins.

Thesis snapshot

With more than +400 blue-chip companies pledging to go cage-free by 2025, in a market where supply won’t be able to meet those demands, EVERY is the only company that provides path and offers solution to achieving those goals.

Thesis points

  • Disrupting a massive $200bn+ egg market
  • EVERY is far ahead of any competitor on key R&D metrics and has a strong IP mode
  • EVERY’s products are set to replace egg one-for-one in existing food supply chain
  • Highly scalable, asset-light business model
  • Revenue generating business with two commercialized products
  • Great existing investors on board
  • Favorable valuation entering Series C raise

MCWIN FEF Value add

Help with introduction of novel ingredients in food service sector through McWin Food Ecosystem Fund‘s restaurants portfolio and deep ties to key players in the food service and hospitality space.

Helping EVERY during its scale up phase.

Supporting EVERY in key strategic decisions.

We chose McWin because of their deep knowledge of the food ecosystem, their global perspective, and what it takes to build long-term focused, multi-generational companies that will fundamentally reshape the world for the better. And that's the kind of company The EVERY Company is.

Arturo Elizondo, CEO